Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2021-02-16

Clinical Trial Update: Effect of Vitamin D3 Supplementation on Arterial and Bone Remodeling in Chronic Kidney Disease Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating whether Vitamin D3 supplementation affects arterial and bone remodeling in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Jewish General Hospital | Conditions: Renal Insufficiency, Chronic, Vascular Stiffness | Phase 4 | Status: COMPLETED